French Weight-Loss Pill Scandal Set for Landmark Trial
September 20, 2019
(Reuters) – Privately-owned Servier, regulator Agence nationale de securite du medicament (ANSM) and 21 defendants will face more than 2,600 plaintiffs who believe the drugmaker deliberately misled patients for decades, helped by lenient authorities. The charges range from deceit to manslaughter which, under French law, could result in fines and jail sentences. The case caused an outcry in France, where authorities have said as many as five million patients were exposed to the drug, known as Mediator, before its withdrawal in 2010, causing between 500 and 2,000 related deaths.